Fund Holdings — Ally Bridge Group (NY) LLC

Total Portfolio Value:
$43.41M
Total Bought:
$18.60M
Total Sold:
$52.28M
Net Transaction:
-$33.68M
Notable People:
Slanix Paul T Alex
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Edgewise Therapeutics, Inc.(EWTX)83,300185,430+102,130$3.38M$7.53M17.34%+$4.14M
ProMIS Neurosciences, Inc.(PMN)620,319620,3190$8.16M$6.73M15.50%-$1.43M
Minerva Neurosciences, Inc.(NERV)2,175,8021,655,500-520,302$12.08M$5.55M12.78%-$6.53M
Amylyx Pharmaceuticals, Inc.(AMLX)0182,000+182,000$0$5.30M12.20%+$5.30M
Shattuck Labs, Inc.(STTK)0625,190+625,190$0$4.26M9.82%+$4.26M
Obsidian Therapeutics Inc0302,449+302,449$0$4.15M9.57%+$4.15M
An2 Therapeutics Inc526,315526,3150$2.55M$2.80M6.45%+$252.6K
Eupraxia Pharmaceuticals Inc.(EPRX)252,175231,122-21,053$1.67M$2.10M4.84%+$436.3K
Avalo Therapeutics, Inc.ADS(AVTX)150,000134,429-15,571$2.77M$2.06M4.75%-$711.2K
Inventiva S.A.ADS(IVA)634,800227,250-407,550$2.40M$838.6K1.93%-$1.56M
Vogenx Inc032,701+32,701$0$745.3K1.72%+$745.3K
Traws Pharma, Inc.(TRAW)786,236786,2360$663.0K$466.9K1.08%-$196.2K
Perspective Therapeutics, Inc.(CATX)743,958163,634-580,324$2.54M$450.0K1.04%-$2.09M
Assembly Biosciences Inc140,00018,298-121,702$3.85M$429.8K0.99%-$3.42M
Alumis Inc76,4590-76,459$2.15M$0—-$2.15M
Axsome Therapeutics, Inc.(AXSM)16,4930-16,493$4.04M$0—-$4.04M
Climb Bio, Inc.(CLYM)249,1720-249,172$3.25M$0—-$3.25M
CytomX Therapeutics, Inc.(CTMX)775,0000-775,000$2.91M$0—-$2.91M
First Tracks Biotherapeutics284,2870-284,287$5.72M$0—-$5.72M
iBio, Inc.(IBIO)390,1470-390,147$682.8K$0—-$682.8K
IDEAYA Biosciences, Inc.(IDYA)67,5000-67,500$2.52M$0—-$2.52M
Kura Oncology, Inc.(KURA)290,0000-290,000$3.18M$0—-$3.18M
Ovid Therapeutics Inc.(OVID)624,5610-624,561$1.68M$0—-$1.68M
Palisade Bio, Inc.(PALI)1,229,0000-1,229,000$2.57M$0—-$2.57M
Solid Biosciences Inc255,9590-255,959$2.56M$0—-$2.56M
UroGen Pharma Ltd.(URGN)69,1830-69,183$2.55M$0—-$2.55M
Whitehawk Therapeutics, Inc.(WHWK)817,9390-817,939$3.75M$0—-$3.75M
Page 1 of 1